FDA Wise To Duck High Court Off-Label Ruling, Attys Say
By Greg Ryan ( January 24, 2013, 9:51 PM EST) -- The U.S. Food and Drug Administration has decided not to challenge the Second Circuit's decision that a sales representative's truthful off-label promotion of a drug was protected speech, a move experts say wisely avoids a U.S. Supreme Court showdown that could have expanded the ruling's reach and given drugmakers more room for off-label marketing....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.